You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))

Not yet recruiting
  • Refractory Cancer
  • Relapsed Cancer
  • Drug Sensitivity Test (DST)
  • Weston, Florida
    Lerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023

Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

Not yet recruiting
  • Pathologically Confirmed Cancer Refractory to Conventional Therapy
  • +7 more
  • SNK02
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 10, 2023

Hawthorn Red Combined Refractory Cancer Pain Trial (Hawthorn red pigment)

Not yet recruiting
  • Hawthorn Red Combined Refractory Cancer Pain
  • Hawthorn red pigment
  • (no location specified)
Sep 26, 2022

Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer Trial in Winston-Salem (Omeprazole 80 mg twice daily)

Recruiting
  • Prostate Cancer
  • +2 more
  • Omeprazole 80 mg twice daily
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Solid Tumor Trial in Huntersville, San Antonio (IGM-7354)

Recruiting
  • Solid Tumor
  • Huntersville, North Carolina
  • +1 more
Jan 25, 2023

Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

Not yet recruiting
  • Head and Neck Cancer
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 18, 2023

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Advanced Cancers, Pain Trial in Houston (Cordotomy, Pain/Symptom Questionnaire, Sharpness Sensory Testing)

Completed
  • Advanced Cancers
  • Pain
  • Cordotomy
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

Not yet recruiting
  • Large Cell Lymphoma, Diffuse
  • +2 more
  • AutoSCT
  • +2 more
  • (no location specified)
May 10, 2023

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Solid Tumor, Adult, Refractory Cancer Trial (GV20-0251)

Not yet recruiting
  • Solid Tumor, Adult
  • Refractory Cancer
  • (no location specified)
Dec 21, 2022

Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)

Withdrawn
  • Relapsed Solid Neoplasm
  • +2 more
  • STI-3258
  • (no location specified)
Jan 24, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 3, 2023

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Advanced, Refractory Cancer Trial in Seoul (Imatinib)

Active, not recruiting
  • Advanced, Refractory Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

Recruiting
  • Cancer
  • +2 more
  • Cellworks Report
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Jan 20, 2023

Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))

Terminated
  • Refractory Cancer
  • BIBW 2992 (Afatinib)
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Jun 29, 2022

Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Edmonton, Alberta, Canada
  • +1 more
Jan 31, 2023

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal

Completed
  • Colorectal Cancer
  • Fruquintinib combined with anti-PD-1 antibodies
  • ChangSha, Hunan, China
    Hunan Cancer Hospital
Aug 27, 2023

Non Small Cell Lung Cancer, Advanced Cancer, Refractory Cancer Trial in Turkey (PVT-1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Adana, Turkey
  • +3 more
May 3, 2022

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer Trial (HST-1011, Cemiplimab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
Dec 14, 2022